STUDYID,USUBJID,SUBJID,SITEID,SITEGR1,ARM,TRT01P,TRT01PN,TRT01A,TRT01AN,TRTSDT,TRTEDT,TRTDUR,AVGDD,CUMDOSE,AGE,AGEGR1,AGEGR1N,AGEU,RACE,RACEN,SEX,ETHNIC,SAFFL,ITTFL,EFFFL,COMP8FL,COMP16FL,COMP24FL,DISCONFL,DSRAEFL,DTHFL,BMIBL,BMIBLGR1,HEIGHTBL,WEIGHTBL,EDUCLVL,DISONSDT,DURDIS,DURDSGR1,VISIT1DT,RFSTDTC,RFENDTC,VISNUMEN,RFENDT,DCDECOD,DCREASCD,MMSETOT
CDISCPILOT01,01-701-1015,1015,701,701,Placebo,Placebo,0,Placebo,0,2014-01-02,2014-07-02,182,0,0,63,<65,1,YEARS,WHITE,1,F,HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,25.1,25-<30,147.3,54.4,16,2010-04-30,43.9,>=12,2013-12-26,2014-01-02,2014-07-02,12,2014-07-02,COMPLETED,Completed,23
CDISCPILOT01,01-701-1023,1023,701,701,Placebo,Placebo,0,Placebo,0,2012-08-05,2012-09-01,28,0,0,64,<65,1,YEARS,WHITE,1,M,HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,30.4,>=30,162.6,80.3,14,2006-03-11,76.4,>=12,2012-07-22,2012-08-05,2012-09-02,5,2012-09-02,ADVERSE EVENT,Adverse Event,23
CDISCPILOT01,01-701-1028,1028,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-07-19,2014-01-14,180,77.7,13986,71,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,31.4,>=30,177.8,99.3,16,2009-12-16,42.8,>=12,2013-07-11,2013-07-19,2014-01-14,12,2014-01-14,COMPLETED,Completed,23
CDISCPILOT01,01-701-1034,1034,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-07-01,2014-12-30,183,76.9,14067,77,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,26.1,25-<30,154.9,62.6,9,2011-09-29,32.9,>=12,2014-06-24,2014-07-01,2014-12-30,12,2014-12-30,COMPLETED,Completed,21
CDISCPILOT01,01-701-1047,1047,701,701,Placebo,Placebo,0,Placebo,0,2013-02-12,2013-03-09,26,0,0,85,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,30.4,>=30,148.6,67.1,8,2009-07-26,42,>=12,2013-01-22,2013-02-12,2013-03-29,6,2013-03-29,ADVERSE EVENT,Adverse Event,23
CDISCPILOT01,01-701-1118,1118,701,701,Placebo,Placebo,0,Placebo,0,2014-03-12,2014-09-09,182,0,0,52,<65,1,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,21.9,<25,180.3,71.2,14,2010-06-24,44.2,>=12,2014-02-27,2014-03-12,2014-09-09,12,2014-09-09,COMPLETED,Completed,20
CDISCPILOT01,01-701-1130,1130,701,701,Placebo,Placebo,0,Placebo,0,2014-02-15,2014-08-16,183,0,0,84,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,27.6,25-<30,169.7,79.4,12,2010-05-22,44.7,>=12,2014-02-09,2014-02-15,2014-08-16,12,2014-08-16,COMPLETED,Completed,19
CDISCPILOT01,01-701-1133,1133,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-10-28,2013-04-28,183,77.2,14121,81,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,28.1,25-<30,162.6,74.4,10,2010-03-11,31.5,>=12,2012-10-23,2012-10-28,2013-04-29,12,2013-04-29,COMPLETED,Completed,21
CDISCPILOT01,01-701-1146,1146,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-05-20,2013-06-26,38,70.3,2673,75,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,24.9,<25,147.3,54,16,2009-11-17,41.7,>=12,2013-05-07,2013-05-20,2013-06-30,7,2013-06-30,ADVERSE EVENT,Adverse Event,22
CDISCPILOT01,01-701-1148,1148,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-08-23,2014-02-20,182,77.1,14040,57,<65,1,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,28.3,25-<30,175.3,87.1,15,2010-12-12,32.1,>=12,2013-08-14,2013-08-23,2014-02-20,12,2014-02-20,COMPLETED,Completed,21
CDISCPILOT01,01-701-1153,1153,701,701,Placebo,Placebo,0,Placebo,0,2013-09-23,2014-03-16,175,0,0,79,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.8,<25,156.2,58.1,6,2005-05-13,99.8,>=12,2013-09-06,2013-09-23,2014-04-01,12,2014-04-01,COMPLETED,Completed,10
CDISCPILOT01,01-701-1180,1180,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-02-12,2013-03-18,35,70.2,2457,56,<65,1,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,27.6,25-<30,180.3,89.8,16,2008-09-21,52.3,>=12,2013-01-28,2013-02-12,2013-03-23,7,2013-03-23,ADVERSE EVENT,Adverse Event,19
CDISCPILOT01,01-701-1181,1181,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-12-05,2013-12-09,5,54,270,79,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,27.8,25-<30,154.9,66.7,15,2008-08-26,63,>=12,2013-11-26,2013-12-05,2013-12-12,4,2013-12-12,ADVERSE EVENT,Adverse Event,10
CDISCPILOT01,01-701-1203,1203,701,701,Placebo,Placebo,0,Placebo,0,2013-02-02,2013-08-03,183,0,0,81,>80,3,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,25.9,25-<30,160,66.2,13,2011-04-19,21.3,>=12,2013-01-25,2013-02-02,2013-08-03,12,2013-08-03,COMPLETED,Completed,21
CDISCPILOT01,01-701-1234,1234,701,701,Placebo,Placebo,0,Placebo,0,2013-03-30,2013-09-22,177,0,0,69,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.4,<25,181.6,77.1,18,2006-08-11,79.3,>=12,2013-03-20,2013-03-30,2013-09-22,12,2013-09-22,COMPLETED,Completed,20
CDISCPILOT01,01-701-1239,1239,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-01-11,2014-07-10,181,76.8,13905,56,<65,1,YEARS,WHITE,1,M,HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,33.6,>=30,168.9,95.9,11,2003-09-23,123.2,>=12,2013-12-28,2014-01-11,2014-07-11,12,2014-07-11,COMPLETED,Completed,23
CDISCPILOT01,01-701-1275,1275,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-02-07,2014-05-31,114,77.2,8802,61,<65,1,YEARS,AMERICAN INDIAN OR ALASKA NATIVE,6,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,,,24.6,<25,167.6,69,12,2011-09-17,28.3,>=12,2014-01-25,2014-02-07,2014-06-14,10,2014-06-14,WITHDRAWAL BY SUBJECT,Withdrew Consent,22
CDISCPILOT01,01-701-1287,1287,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-01-25,2014-07-26,183,76.3,13959,56,<65,1,YEARS,WHITE,1,F,HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.5,<25,154.9,56.3,14,2009-10-30,50.6,>=12,2014-01-17,2014-01-25,2014-07-26,12,2014-07-26,COMPLETED,Completed,22
CDISCPILOT01,01-701-1302,1302,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-08-29,2013-11-05,69,74,5103,61,<65,1,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,26,25-<30,177.8,82.1,15,2007-02-09,78.4,>=12,2013-08-20,2013-08-29,2013-11-05,9,2013-11-05,ADVERSE EVENT,Adverse Event,23
CDISCPILOT01,01-701-1345,1345,701,701,Placebo,Placebo,0,Placebo,0,2013-10-08,2014-03-18,162,0,0,63,<65,1,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,Y,,,18.6,<25,174,56.3,15,2010-11-05,34.9,>=12,2013-10-01,2013-10-08,2014-03-18,12,2014-03-18,STUDY TERMINATED BY SPONSOR,Sponsor Decision,23
CDISCPILOT01,01-701-1360,1360,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-07-31,2013-08-05,6,54,324,67,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,,,29,25-<30,166.4,80.3,10,2008-12-02,55.7,>=12,2013-07-24,2013-07-31,2013-08-14,4,2013-08-14,PHYSICIAN DECISION,Physician Decision,23
CDISCPILOT01,01-701-1363,1363,701,701,Placebo,Placebo,0,Placebo,0,2013-05-30,2013-11-27,182,0,0,81,>80,3,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.9,<25,161.3,64.9,13,2005-10-20,91,>=12,2013-05-20,2013-05-30,2013-11-27,12,2013-11-27,COMPLETED,Completed,22
CDISCPILOT01,01-701-1383,1383,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-02-04,2013-08-06,184,77.6,14283,72,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,31.6,>=30,163.8,84.8,12,2006-08-20,77.1,>=12,2013-01-22,2013-02-04,2013-08-06,12,2013-08-06,COMPLETED,Completed,22
CDISCPILOT01,01-701-1387,1387,701,701,Placebo,Placebo,0,Placebo,0,2014-03-12,2014-03-25,14,0,0,87,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,,,22.5,<25,162.6,59.4,12,2003-08-17,126.3,>=12,2014-02-23,2014-03-12,2014-03-25,4,2014-03-25,PROTOCOL VIOLATION,Protocol Violation,11
CDISCPILOT01,01-701-1392,1392,701,701,Placebo,Placebo,0,Placebo,0,2012-10-28,2013-04-28,183,0,0,78,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,28.9,25-<30,167.6,81.2,16,2010-04-25,29.8,>=12,2012-10-17,2012-10-28,2013-04-28,12,2013-04-28,COMPLETED,Completed,23
CDISCPILOT01,01-701-1415,1415,701,701,Placebo,Placebo,0,Placebo,0,2013-09-23,2014-03-24,183,0,0,85,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,25,25-<30,175.3,76.7,10,1998-06-13,183.1,>=12,2013-09-15,2013-09-23,2014-03-24,12,2014-03-24,COMPLETED,Completed,18
CDISCPILOT01,01-701-1440,1440,701,701,Placebo,Placebo,0,Placebo,0,2013-08-08,2014-02-05,182,0,0,70,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,20.2,<25,156.2,49.4,18,2011-04-07,27.6,>=12,2013-07-24,2013-08-08,2014-02-05,12,2014-02-05,COMPLETED,Completed,22
CDISCPILOT01,01-701-1444,1444,701,701,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-01-05,2013-02-12,39,71.3,2781,63,<65,1,YEARS,WHITE,1,M,HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,34.5,>=30,171.5,101.6,14,2008-05-21,55.4,>=12,2012-12-31,2013-01-05,2013-02-13,7,2013-02-13,ADVERSE EVENT,Adverse Event,23
CDISCPILOT01,01-703-1042,1042,703,703,Placebo,Placebo,0,Placebo,0,2013-03-02,2013-08-31,183,0,0,64,<65,1,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.5,<25,177.8,74.4,12,2008-07-23,55.1,>=12,2013-02-23,2013-03-02,2013-08-31,12,2013-08-31,COMPLETED,Completed,23
CDISCPILOT01,01-703-1076,1076,703,703,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-10-25,2013-12-24,61,75.2,4590,69,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,32,>=30,165.1,87.1,10,2012-08-27,13.7,>=12,2013-10-17,2013-10-25,2013-12-24,9,2013-12-24,ADVERSE EVENT,Adverse Event,23
CDISCPILOT01,01-703-1096,1096,703,703,Placebo,Placebo,0,Placebo,0,2013-01-25,2013-03-16,51,0,0,81,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,,,31.7,>=30,160,81.2,6,2006-12-20,72,>=12,2012-12-19,2013-01-25,2013-03-29,7,2013-03-29,LOST TO FOLLOW-UP,Lost to Follow-up,22
CDISCPILOT01,01-703-1100,1100,703,703,Placebo,Placebo,0,Placebo,0,2013-03-13,2013-09-14,186,0,0,84,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,21.8,<25,167.6,61.2,8,2010-12-02,26.9,>=12,2013-02-28,2013-03-13,2013-09-14,12,2013-09-14,COMPLETED,Completed,22
CDISCPILOT01,01-703-1175,1175,703,703,Placebo,Placebo,0,Placebo,0,2013-12-20,2013-12-26,7,0,0,75,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,,,26.6,25-<30,170.2,77.1,16,2010-09-19,38.8,>=12,2013-12-13,2013-12-20,2013-12-31,4,2013-12-31,PROTOCOL VIOLATION,I/E Not Met,11
CDISCPILOT01,01-703-1210,1210,703,703,Placebo,Placebo,0,Placebo,0,2013-03-16,2013-09-06,175,0,0,72,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.8,<25,144.8,49.9,12,2010-02-18,36.6,>=12,2013-03-08,2013-03-16,2013-09-06,12,2013-09-06,COMPLETED,Completed,19
CDISCPILOT01,01-703-1258,1258,703,703,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-07-20,2013-01-11,176,77.3,13608,78,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,Y,Y,,24.8,<25,154.9,59.4,12,2006-02-17,76.7,>=12,2012-07-10,2012-07-20,2013-01-21,12,2013-01-21,ADVERSE EVENT,Adverse Event,13
CDISCPILOT01,01-703-1295,1295,703,703,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-11-21,2014-04-19,150,78.3,11745,88,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,,,22.7,<25,157.5,56.3,8,2012-04-05,18.7,>=12,2013-10-24,2013-11-21,2014-05-19,11,2014-05-19,WITHDRAWAL BY SUBJECT,Withdrew Consent,20
CDISCPILOT01,01-703-1299,1299,703,703,Placebo,Placebo,0,Placebo,0,2012-09-12,2013-03-13,183,0,0,81,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,19.2,<25,153.7,45.4,12,2011-09-16,11.8,<12,2012-09-07,2012-09-12,2013-03-13,12,2013-03-13,COMPLETED,Completed,23
CDISCPILOT01,01-703-1335,1335,703,703,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-03-17,2014-05-07,52,73.2,3807,67,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,,,23,<25,154.9,55.3,11,2008-01-30,73,>=12,2014-02-28,2014-03-17,2014-05-24,7,2014-05-24,PROTOCOL VIOLATION,Protocol Violation,10
CDISCPILOT01,01-703-1403,1403,703,703,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-12-12,2012-12-13,2,54,108,67,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,Y,,25.4,25-<30,177.8,80.3,12,2010-12-07,24,>=12,2012-12-05,2012-12-12,2012-12-19,4,2012-12-19,ADVERSE EVENT,Adverse Event,23
CDISCPILOT01,01-703-1439,1439,703,703,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-03-12,2014-09-11,184,76.7,14121,76,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.8,<25,160,63.5,12,2010-07-29,43.2,>=12,2014-03-04,2014-03-12,2014-09-11,12,2014-09-11,COMPLETED,Completed,16
CDISCPILOT01,01-705-1018,1018,705,705,Placebo,Placebo,0,Placebo,0,2013-07-05,2013-07-12,8,0,0,69,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,,,22.6,<25,147.3,49,6,2009-11-21,43.3,>=12,2013-06-30,2013-07-05,2013-07-12,4,2013-07-12,WITHDRAWAL BY SUBJECT,Withdrew Consent,18
CDISCPILOT01,01-705-1059,1059,705,705,Placebo,Placebo,0,Placebo,0,2013-08-05,2013-12-05,123,0,0,66,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,Y,,20.4,<25,162.6,54,12,2009-07-20,48.5,>=12,2013-08-02,2013-08-05,2013-12-05,10,2013-12-05,ADVERSE EVENT,Adverse Event,16
CDISCPILOT01,01-705-1186,1186,705,705,Placebo,Placebo,0,Placebo,0,2014-01-08,2014-01-26,19,0,0,84,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,,,19.7,<25,142.2,39.9,12,2011-07-03,30.1,>=12,2014-01-03,2014-01-08,2014-02-07,5,2014-02-07,PHYSICIAN DECISION,Physician Decision,15
CDISCPILOT01,01-705-1280,1280,705,705,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-01-17,2014-07-25,190,76.9,14607,56,<65,1,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,28,25-<30,157.5,69.4,12,2013-01-04,12.3,>=12,2014-01-11,2014-01-17,2014-07-25,12,2014-07-25,COMPLETED,Completed,23
CDISCPILOT01,01-705-1281,1281,705,705,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-11-28,2014-02-27,92,75.7,6966,73,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,Y,,31.4,>=30,152.4,73,12,2012-11-05,12.7,>=12,2013-11-26,2013-11-28,2014-03-17,10,2014-03-17,ADVERSE EVENT,Adverse Event,23
CDISCPILOT01,01-705-1282,1282,705,705,Placebo,Placebo,0,Placebo,0,2012-12-26,2013-06-24,181,0,0,70,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,30.4,>=30,154.9,73,12,2006-12-06,72.6,>=12,2012-12-23,2012-12-26,2013-06-24,12,2013-06-24,COMPLETED,Completed,10
CDISCPILOT01,01-705-1303,1303,705,705,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-12-16,2014-06-02,169,78.6,13284,72,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,Y,,27.5,25-<30,175.3,84.4,12,2010-12-15,35.9,>=12,2013-12-10,2013-12-16,2014-06-02,11,2014-06-02,ADVERSE EVENT,Adverse Event,19
CDISCPILOT01,01-705-1310,1310,705,705,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-11-02,2014-01-23,83,74.2,6156,74,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,22.7,<25,146.1,48.5,12,2011-10-30,23.9,>=12,2013-10-26,2013-11-02,2014-01-23,9,2014-01-23,ADVERSE EVENT,Adverse Event,20
CDISCPILOT01,01-705-1349,1349,705,705,Placebo,Placebo,0,Placebo,0,2013-03-10,2013-09-08,183,0,0,86,>80,3,YEARS,WHITE,1,F,HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,21.2,<25,144.8,44.5,10,2007-03-23,71.2,>=12,2013-02-24,2013-03-10,2013-09-08,12,2013-09-08,COMPLETED,Completed,15
CDISCPILOT01,01-705-1377,1377,705,705,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-01-04,2014-03-07,63,71.6,4509,63,<65,1,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,,,21,<25,165.1,57.2,6,2012-01-05,23.8,>=12,2013-12-29,2014-01-04,2014-03-07,7,2014-03-07,WITHDRAWAL BY SUBJECT,Withdrew Consent,14
CDISCPILOT01,01-705-1382,1382,705,705,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-05-13,2013-05-13,1,54,54,82,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,,,33.2,>=30,170.2,96.2,12,2012-05-03,12.2,>=12,2013-05-09,2013-05-13,2013-05-13,4,2013-05-13,PROTOCOL VIOLATION,I/E Not Met,19
CDISCPILOT01,01-707-1206,1206,707,900,Placebo,Placebo,0,Placebo,0,2013-10-28,2014-04-26,181,0,0,65,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.6,<25,174,74.4,7,2012-08-23,13.9,>=12,2013-10-20,2013-10-28,2014-04-27,12,2014-04-27,COMPLETED,Completed,21
CDISCPILOT01,01-709-1001,1001,709,709,Placebo,Placebo,0,Placebo,0,2013-10-08,2014-04-08,183,0,0,76,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,25.2,25-<30,170.2,73,12,2011-01-30,31.7,>=12,2013-09-20,2013-10-08,2014-04-08,12,2014-04-08,COMPLETED,Completed,15
CDISCPILOT01,01-709-1029,1029,709,709,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-12-25,2013-06-26,184,76.6,14094,82,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.1,<25,172.7,69,20,2009-06-02,42.3,>=12,2012-12-10,2012-12-25,2013-06-26,12,2013-06-26,COMPLETED,Completed,16
CDISCPILOT01,01-709-1088,1088,709,709,Placebo,Placebo,0,Placebo,0,2014-04-12,2014-10-09,181,0,0,69,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.8,<25,179.1,79.4,16,2012-02-25,25.1,>=12,2014-03-30,2014-04-12,2014-10-09,12,2014-10-09,COMPLETED,Completed,23
CDISCPILOT01,01-709-1099,1099,709,709,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-10-25,2014-04-25,183,76.1,13932,79,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,19.6,<25,165.1,53.5,12,2009-04-20,53.8,>=12,2013-10-14,2013-10-25,2014-04-25,12,2014-04-25,COMPLETED,Completed,11
CDISCPILOT01,01-709-1168,1168,709,709,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-08-02,2013-09-26,56,73.3,4104,72,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,27.6,25-<30,149.9,62.1,12,2009-10-29,44.9,>=12,2013-07-25,2013-08-02,2013-09-27,8,2013-09-27,ADVERSE EVENT,Adverse Event,20
CDISCPILOT01,01-709-1238,1238,709,709,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-05-15,2013-08-06,84,76.2,6399,69,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,28.5,25-<30,170.2,82.6,8,2011-10-13,18.7,>=12,2013-05-02,2013-05-15,2013-08-07,9,2013-08-07,ADVERSE EVENT,Adverse Event,24
CDISCPILOT01,01-709-1259,1259,709,709,Placebo,Placebo,0,Placebo,0,2013-01-26,2013-06-13,139,0,0,82,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,,,21.9,<25,172.7,65.3,18,2008-08-06,53.3,>=12,2013-01-13,2013-01-26,2013-06-13,11,2013-06-13,LACK OF EFFICACY,Lack of Efficacy,20
CDISCPILOT01,01-709-1301,1301,709,709,Placebo,Placebo,0,Placebo,0,2013-07-19,2014-01-17,183,0,0,62,<65,1,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.6,<25,146.1,50.4,10,2009-02-04,53.3,>=12,2013-07-14,2013-07-19,2014-01-17,12,2014-01-17,COMPLETED,Completed,10
CDISCPILOT01,01-709-1306,1306,709,709,Placebo,Placebo,0,Placebo,0,2014-02-03,2014-06-16,134,0,0,60,<65,1,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,Y,,18.5,<25,154.9,44.5,12,2009-02-02,59.6,>=12,2014-01-19,2014-02-03,2014-06-25,11,2014-06-25,ADVERSE EVENT,Adverse Event,21
CDISCPILOT01,01-709-1309,1309,709,709,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-06-19,2013-12-19,184,77,14175,65,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.8,<25,177.8,78.5,16,2009-12-21,41.6,>=12,2013-06-09,2013-06-19,2013-12-19,12,2013-12-19,COMPLETED,Completed,17
CDISCPILOT01,01-709-1312,1312,709,709,Placebo,Placebo,0,Placebo,0,2014-04-20,2014-10-19,183,0,0,68,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,20.9,<25,160,53.5,13,2010-07-30,44.5,>=12,2014-04-13,2014-04-20,2014-10-19,12,2014-10-19,COMPLETED,Completed,14
CDISCPILOT01,01-709-1329,1329,709,709,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-08-15,2013-08-25,11,54,594,70,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,,,26.5,25-<30,170.2,76.7,16,2009-03-08,52.8,>=12,2013-08-01,2013-08-15,2013-08-29,4,2013-08-29,WITHDRAWAL BY SUBJECT,Withdrew Consent,10
CDISCPILOT01,01-709-1339,1339,709,709,Placebo,Placebo,0,Placebo,0,2012-12-23,2013-06-24,184,0,0,81,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,25.4,25-<30,175.3,78,16,2010-03-03,33.5,>=12,2012-12-15,2012-12-23,2013-06-24,12,2013-06-24,COMPLETED,Completed,23
CDISCPILOT01,01-709-1424,1424,709,709,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-03-03,2013-03-07,5,54,270,77,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,22.6,<25,174,68.5,16,2007-09-12,65.2,>=12,2013-02-15,2013-03-03,2013-03-08,4,2013-03-08,ADVERSE EVENT,Adverse Event,18
CDISCPILOT01,01-711-1012,1012,711,900,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-04-03,2013-04-29,27,66,1782,67,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,28,25-<30,170.2,81,12,2011-07-25,19.9,>=12,2013-03-20,2013-04-03,2013-05-02,5,2013-05-02,ADVERSE EVENT,Adverse Event,18
CDISCPILOT01,01-711-1036,1036,711,900,Placebo,Placebo,0,Placebo,0,2012-07-29,2013-02-10,197,0,0,70,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.4,<25,172,69.2,9,2009-03-05,40.5,>=12,2012-07-20,2012-07-29,2013-02-10,12,2013-02-10,COMPLETED,Completed,23
CDISCPILOT01,01-711-1433,1433,711,900,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-01-27,2013-02-05,10,54,540,84,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,Y,,20.9,<25,157.5,51.9,12,2012-02-02,11.7,<12,2013-01-23,2013-01-27,2013-02-06,4,2013-02-06,ADVERSE EVENT,Adverse Event,18
CDISCPILOT01,01-713-1106,1106,713,713,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-10-31,2013-05-06,188,76.7,14418,74,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,19.6,<25,164.8,53.1,16,2010-01-16,32.6,>=12,2012-10-03,2012-10-31,2013-05-06,12,2013-05-06,COMPLETED,Completed,23
CDISCPILOT01,01-713-1141,1141,713,713,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-05-31,2013-07-01,32,68.3,2187,79,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,Y,,23.5,<25,170,68,13,2006-11-24,78,>=12,2013-05-23,2013-05-31,2013-08-06,7,2013-08-06,ADVERSE EVENT,Adverse Event,18
CDISCPILOT01,01-713-1179,1179,713,713,Placebo,Placebo,0,Placebo,0,2013-08-09,2014-02-05,181,0,0,64,<65,1,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,20.3,<25,165.1,55.3,12,2011-05-04,26.3,>=12,2013-07-11,2013-08-09,2014-02-05,12,2014-02-05,COMPLETED,Completed,21
CDISCPILOT01,01-713-1209,1209,713,713,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-05-27,2013-11-22,180,77,13851,77,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,19.2,<25,165.1,52.2,12,2010-07-14,34.1,>=12,2013-05-16,2013-05-27,2013-11-22,12,2013-11-22,COMPLETED,Completed,23
CDISCPILOT01,01-713-1256,1256,713,713,Placebo,Placebo,0,Placebo,0,2012-09-19,2013-03-25,188,0,0,71,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.7,<25,180.3,77.1,16,2009-02-08,43.1,>=12,2012-09-10,2012-09-19,2013-03-25,12,2013-03-25,COMPLETED,Completed,13
CDISCPILOT01,01-713-1269,1269,713,713,Placebo,Placebo,0,Placebo,0,2014-01-27,2014-07-28,183,0,0,73,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,21.9,<25,185.4,75.3,16,2012-03-21,21.8,>=12,2014-01-14,2014-01-27,2014-07-28,12,2014-07-28,COMPLETED,Completed,23
CDISCPILOT01,01-715-1155,1155,715,900,Placebo,Placebo,0,Placebo,0,2013-12-13,2014-01-25,44,0,0,59,<65,1,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,,,23.3,<25,165.1,63.5,12,2010-12-09,35.7,>=12,2013-11-29,2013-12-13,2014-04-26,7,2014-04-26,WITHDRAWAL BY SUBJECT,Withdrew Consent,10
CDISCPILOT01,01-715-1207,1207,715,900,Placebo,Placebo,0,Placebo,0,2012-11-18,2013-05-27,191,0,0,78,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,21.3,<25,152.4,49.4,7,2010-04-06,31.3,>=12,2012-11-12,2012-11-18,2013-06-01,12,2013-06-01,COMPLETED,Completed,20
CDISCPILOT01,01-715-1319,1319,715,900,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-02-17,2013-03-05,17,57.2,972,65,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,,,25.4,25-<30,172.7,75.8,13,2007-08-12,65.8,>=12,2013-02-03,2013-02-17,2013-03-18,5,2013-03-18,WITHDRAWAL BY SUBJECT,Withdrew Consent,12
CDISCPILOT01,01-715-1321,1321,715,900,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-02-11,2014-04-21,70,74.8,5238,75,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,22.7,<25,162.6,59.9,12,2010-11-30,38.3,>=12,2014-02-06,2014-02-11,2014-04-22,9,2014-04-22,ADVERSE EVENT,Adverse Event,23
CDISCPILOT01,01-715-1397,1397,715,900,Placebo,Placebo,0,Placebo,0,2013-04-03,2013-10-02,183,0,0,76,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,28.9,25-<30,152.4,67.1,11,2012-05-16,10.2,<12,2013-03-20,2013-04-03,2013-10-03,12,2013-10-03,COMPLETED,Completed,22
CDISCPILOT01,01-717-1109,1109,717,900,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-01-27,2014-07-28,183,77.3,14148,84,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,13.7,<25,180.3,44.5,17,2012-03-11,22.4,>=12,2014-01-20,2014-01-27,2014-07-28,12,2014-07-28,COMPLETED,Completed,20
CDISCPILOT01,01-717-1174,1174,717,900,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-01-22,2013-07-24,184,76.5,14067,73,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.2,<25,167.6,68,16,2010-09-02,28.5,>=12,2013-01-16,2013-01-22,2013-07-24,12,2013-07-24,COMPLETED,Completed,22
CDISCPILOT01,01-717-1201,1201,717,900,Placebo,Placebo,0,Placebo,0,2013-12-19,2014-02-21,65,0,0,85,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,,,26.6,25-<30,160,68,12,2011-03-23,32.7,>=12,2013-12-12,2013-12-19,2014-02-21,8,2014-02-21,LACK OF EFFICACY,Lack of Efficacy,23
CDISCPILOT01,01-717-1344,1344,717,900,Placebo,Placebo,0,Placebo,0,2014-01-11,2014-03-14,63,0,0,64,<65,1,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,,,21.7,<25,163.5,58.1,16,2008-09-10,63.7,>=12,2014-01-01,2014-01-11,2014-03-14,8,2014-03-14,LACK OF EFFICACY,Lack of Efficacy,21
CDISCPILOT01,01-717-1357,1357,717,900,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-05-01,2013-10-14,167,78.6,13122,77,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,Y,,,24.7,<25,181.6,81.3,14,2010-02-20,38,>=12,2013-04-21,2013-05-01,2013-10-20,12,2013-10-20,STUDY TERMINATED BY SPONSOR,Sponsor Decision,12
CDISCPILOT02,02-704-1008,1008,704,704,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-01-13,2013-02-21,40,70.2,2808,76,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,21.3,<25,148,46.7,12,2011-10-17,14.7,>=12,2013-01-06,2013-01-13,2013-02-25,7,2013-02-25,ADVERSE EVENT,Adverse Event,21
CDISCPILOT02,02-704-1010,1010,704,704,Placebo,Placebo,0,Placebo,0,2014-02-21,2014-07-08,138,0,0,80,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,,,25.6,25-<30,177.8,81,14,2006-01-02,97.2,>=12,2014-02-08,2014-02-21,2014-07-09,11,2014-07-09,WITHDRAWAL BY SUBJECT,Withdrew Consent,17
CDISCPILOT02,02-704-1017,1017,704,704,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-10-06,2013-11-18,44,72.4,3186,77,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,21.8,<25,170.2,63.1,12,2011-03-27,29.9,>=12,2013-09-20,2013-10-06,2013-11-24,7,2013-11-24,ADVERSE EVENT,Adverse Event,21
CDISCPILOT02,02-704-1065,1065,704,704,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-10-24,2013-12-22,60,74.3,4455,75,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,24.8,<25,180.3,80.7,12,2010-03-23,42.9,>=12,2013-10-17,2013-10-24,2013-12-24,9,2013-12-24,ADVERSE EVENT,Adverse Event,20
CDISCPILOT02,02-704-1074,1074,704,704,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2014-01-22,2014-03-20,58,72.2,4185,80,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,27,25-<30,167.6,75.8,16,2009-01-30,59.7,>=12,2014-01-19,2014-01-22,2014-03-31,8,2014-03-31,ADVERSE EVENT,Adverse Event,17
CDISCPILOT02,02-704-1093,1093,704,704,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-03-15,2013-06-17,95,76.5,7263,79,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,Y,,24.3,<25,174,73.5,12,2010-07-17,31.3,>=12,2013-02-22,2013-03-15,2013-06-20,10,2013-06-20,ADVERSE EVENT,Adverse Event,18
CDISCPILOT02,02-704-1127,1127,704,704,Placebo,Placebo,0,Placebo,0,2013-10-02,2014-03-31,181,0,0,84,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,15.1,<25,165.1,41.1,12,2008-09-11,60.2,>=12,2013-09-16,2013-10-02,2014-03-31,12,2014-03-31,COMPLETED,Completed,22
CDISCPILOT02,02-704-1164,1164,704,704,Placebo,Placebo,0,Placebo,0,2012-09-19,2013-04-04,198,0,0,67,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,20.1,<25,157.5,49.9,10,2011-03-04,18.3,>=12,2012-09-11,2012-09-19,2013-04-04,12,2013-04-04,COMPLETED,Completed,16
CDISCPILOT02,02-704-1233,1233,704,704,Placebo,Placebo,0,Placebo,0,2013-03-21,2013-07-14,116,0,0,87,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,,,21.3,<25,147.3,46.3,16,2011-01-15,25.8,>=12,2013-03-08,2013-03-21,2013-07-14,11,2013-07-14,WITHDRAWAL BY SUBJECT,Withdrew Consent,15
CDISCPILOT02,02-704-1241,1241,704,704,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-08-25,2013-10-09,46,74,3402,86,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,25.2,25-<30,170.2,73,14,2011-07-25,24.7,>=12,2013-08-14,2013-08-25,2013-10-31,8,2013-10-31,ADVERSE EVENT,Adverse Event,21
CDISCPILOT02,02-704-1260,1260,704,704,Placebo,Placebo,0,Placebo,0,2012-08-30,2012-11-04,67,0,0,71,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,,,19.1,<25,160,48.8,16,2002-11-29,116.8,>=12,2012-08-23,2012-08-30,2013-01-18,9,2013-01-18,WITHDRAWAL BY SUBJECT,Withdrew Consent,16
CDISCPILOT02,02-704-1266,1266,704,704,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-10-13,2013-12-06,55,73.6,4050,82,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,29.2,25-<30,174,88.5,12,2011-12-02,22.1,>=12,2013-10-05,2013-10-13,2013-12-06,8,2013-12-06,ADVERSE EVENT,Adverse Event,16
CDISCPILOT02,02-704-1332,1332,704,704,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-12-09,2014-02-14,68,75,5103,80,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,26.2,25-<30,173,78.5,9,2011-11-09,24.5,>=12,2013-11-24,2013-12-09,2014-02-16,9,2014-02-16,ADVERSE EVENT,Adverse Event,22
CDISCPILOT02,02-704-1351,1351,704,704,Placebo,Placebo,0,Placebo,0,2013-10-12,2014-04-18,189,0,0,70,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.9,<25,175.3,73.5,12,2012-09-10,12.6,>=12,2013-09-26,2013-10-12,2014-04-18,12,2014-04-18,COMPLETED,Completed,22
CDISCPILOT02,02-704-1388,1388,704,704,Placebo,Placebo,0,Placebo,0,2012-12-07,2013-06-11,187,0,0,81,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,18.8,<25,176.5,58.5,11,2010-10-26,25.1,>=12,2012-11-28,2012-12-07,2013-06-19,12,2013-06-19,COMPLETED,Completed,20
CDISCPILOT02,02-704-1435,1435,704,704,Placebo,Placebo,0,Placebo,0,2012-11-17,2013-01-09,54,0,0,74,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,,,27.1,25-<30,167.6,76.2,16,2010-01-20,33.4,>=12,2012-11-01,2012-11-17,2013-01-12,8,2013-01-12,WITHDRAWAL BY SUBJECT,Withdrew Consent,20
CDISCPILOT02,02-704-1445,1445,704,704,Placebo,Placebo,0,Placebo,0,2014-05-11,2014-11-01,175,0,0,75,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,Y,,Y,22.8,<25,177.8,72.1,12,2012-11-11,17.6,>=12,2014-05-01,2014-05-11,2014-11-01,12,2014-11-01,DEATH,Death,23
CDISCPILOT02,02-706-1041,1041,706,900,Placebo,Placebo,0,Placebo,0,2013-12-31,2014-07-28,210,0,0,64,<65,1,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,20.9,<25,167.6,58.7,15,2011-11-18,25.1,>=12,2013-12-21,2013-12-31,2014-07-29,12,2014-07-29,COMPLETED,Completed,20
CDISCPILOT02,02-706-1049,1049,706,900,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-05-14,2013-06-18,36,69.8,2511,60,<65,1,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,20.6,<25,167.6,57.8,11,2010-05-02,36,>=12,2013-04-30,2013-05-14,2013-06-25,7,2013-06-25,ADVERSE EVENT,Adverse Event,16
CDISCPILOT02,02-708-1087,1087,708,708,Placebo,Placebo,0,Placebo,0,2012-10-22,2013-04-28,189,0,0,74,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,26.9,25-<30,157.5,66.7,12,2008-09-02,49.1,>=12,2012-10-06,2012-10-22,2013-04-28,12,2013-04-28,COMPLETED,Completed,17
CDISCPILOT02,02-708-1158,1158,708,708,Placebo,Placebo,0,Placebo,0,2014-02-08,2014-03-21,42,0,0,81,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,27.8,25-<30,162.6,73.5,8,2010-08-01,42.1,>=12,2014-02-01,2014-02-08,2014-03-22,7,2014-03-22,ADVERSE EVENT,Adverse Event,16
CDISCPILOT02,02-708-1171,1171,708,708,Placebo,Placebo,0,Placebo,0,2012-12-06,2013-06-04,181,0,0,77,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,20.8,<25,162.6,54.9,9,2010-09-24,26.1,>=12,2012-11-25,2012-12-06,2013-06-04,12,2013-06-04,COMPLETED,Completed,13
CDISCPILOT02,02-708-1178,1178,708,708,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-12-29,2014-04-06,99,75.3,7452,77,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,,,23,<25,165.1,62.8,8,2008-08-10,64.1,>=12,2013-12-13,2013-12-29,2014-04-06,9,2014-04-06,PHYSICIAN DECISION,Physician Decision,10
CDISCPILOT02,02-708-1213,1213,708,708,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-02-09,2013-02-22,14,54,756,76,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,Y,,15.3,<25,165.1,41.7,12,2011-02-06,23.9,>=12,2013-02-01,2013-02-09,2013-02-26,5,2013-02-26,ADVERSE EVENT,Adverse Event,14
CDISCPILOT02,02-708-1216,1216,708,708,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-10-24,2012-11-29,37,69.3,2565,78,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,25.9,25-<30,172.7,77.1,12,2001-07-15,135,>=12,2012-10-14,2012-10-24,2012-12-06,7,2012-12-06,ADVERSE EVENT,Adverse Event,17
CDISCPILOT02,02-708-1236,1236,708,708,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-09-21,2013-09-21,1,54,54,86,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,,,23.4,<25,152.4,54.4,8,2012-09-08,12,>=12,2013-09-08,2013-09-21,2013-09-26,4,2013-09-26,WITHDRAWAL BY SUBJECT,Withdrew Consent,22
CDISCPILOT02,02-708-1253,1253,708,708,Placebo,Placebo,0,Placebo,0,2013-05-07,2013-11-05,183,0,0,61,<65,1,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,22.1,<25,185.4,75.8,12,2009-03-12,49.5,>=12,2013-04-26,2013-05-07,2013-11-05,12,2013-11-05,COMPLETED,Completed,12
CDISCPILOT02,02-708-1286,1286,708,708,Placebo,Placebo,0,Placebo,0,2013-09-10,2014-03-08,180,0,0,80,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,32.8,>=30,152.4,76.2,12,2001-10-03,142.8,>=12,2013-08-25,2013-09-10,2014-03-08,12,2014-03-08,COMPLETED,Completed,10
CDISCPILOT02,02-708-1296,1296,708,708,Placebo,Placebo,0,Placebo,0,2013-06-14,2013-12-12,182,0,0,57,<65,1,YEARS,BLACK OR AFRICAN AMERICAN,2,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,27.9,25-<30,170.2,80.7,18,2010-02-03,40.1,>=12,2013-06-07,2013-06-14,2013-12-12,12,2013-12-12,COMPLETED,Completed,16
CDISCPILOT02,02-708-1316,1316,708,708,Placebo,Placebo,0,Placebo,0,2013-08-23,2014-03-01,191,0,0,74,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,23.4,<25,160,59.9,12,2011-08-08,24.3,>=12,2013-08-15,2013-08-23,2014-03-01,12,2014-03-01,COMPLETED,Completed,22
CDISCPILOT02,02-708-1336,1336,708,708,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-12-07,2013-06-05,181,76.7,13878,73,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.1,<25,190.5,87.5,18,2002-12-01,119.7,>=12,2012-11-21,2012-12-07,2013-06-05,12,2013-06-05,COMPLETED,Completed,15
CDISCPILOT02,02-708-1342,1342,708,708,Placebo,Placebo,0,Placebo,0,2012-12-29,2013-06-28,182,0,0,59,<65,1,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,20.4,<25,170.2,59,13,2010-09-24,26.9,>=12,2012-12-21,2012-12-29,2013-06-28,12,2013-06-28,COMPLETED,Completed,18
CDISCPILOT02,02-708-1347,1347,708,708,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-04-20,2013-06-18,60,74.3,4455,61,<65,1,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,29.2,25-<30,160,74.8,12,2009-05-23,46.7,>=12,2013-04-11,2013-04-20,2013-06-18,9,2013-06-18,ADVERSE EVENT,Adverse Event,22
CDISCPILOT02,02-708-1372,1372,708,708,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-04-12,2013-04-19,8,54,432,84,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,,,30.7,>=30,170.2,88.9,8,2007-09-17,66.6,>=12,2013-04-03,2013-04-12,2013-05-10,4,2013-05-10,PROTOCOL VIOLATION,I/E Not Met,17
CDISCPILOT02,02-708-1378,1378,708,708,Placebo,Placebo,0,Placebo,0,2013-09-03,2014-01-28,148,0,0,67,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,,,24.3,<25,170.2,70.3,13,2009-03-16,53.3,>=12,2013-08-24,2013-09-03,2014-01-28,11,2014-01-28,STUDY TERMINATED BY SPONSOR,Sponsor Decision,20
CDISCPILOT02,02-708-1406,1406,708,708,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-12-26,2014-07-02,189,76.6,14472,71,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,22.1,<25,157.5,54.9,13,2010-06-24,41.5,>=12,2013-12-06,2013-12-26,2014-07-02,12,2014-07-02,COMPLETED,Completed,15
CDISCPILOT02,02-710-1006,1006,710,710,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-02-10,2013-08-09,181,77.1,13959,77,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,25.1,25-<30,170.2,72.6,12,2012-02-10,11.6,<12,2013-01-27,2013-02-10,2013-08-10,12,2013-08-10,COMPLETED,Completed,12
CDISCPILOT02,02-710-1021,1021,710,710,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-09-27,2013-10-29,33,68.7,2268,79,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,M,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,Y,,21.3,<25,162.6,56.3,8,2012-07-09,14.4,>=12,2013-09-19,2013-09-27,2013-11-12,7,2013-11-12,ADVERSE EVENT,Adverse Event,11
CDISCPILOT02,02-710-1027,1027,710,710,Placebo,Placebo,0,Placebo,0,2014-02-28,2014-08-29,183,0,0,83,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.4,<25,170.2,70.8,12,2012-02-04,24,>=12,2014-02-03,2014-02-28,2014-08-29,12,2014-08-29,COMPLETED,Completed,20
CDISCPILOT02,02-710-1060,1060,710,710,Placebo,Placebo,0,Placebo,0,2013-01-01,2013-07-05,186,0,0,82,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,21,<25,182.9,70.3,16,2010-09-14,27.4,>=12,2012-12-24,2013-01-01,2013-07-05,12,2013-07-05,COMPLETED,Completed,23
CDISCPILOT02,02-710-1070,1070,710,710,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-09-08,2013-01-22,137,78,10692,85,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,Y,,21.8,<25,149.9,49,10,2010-09-08,23.7,>=12,2012-08-28,2012-09-08,2013-02-23,11,2013-02-23,ADVERSE EVENT,Adverse Event,10
CDISCPILOT02,02-710-1077,1077,710,710,Placebo,Placebo,0,Placebo,0,2013-11-17,2014-05-18,183,0,0,76,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,18.5,<25,162.6,49,12,2011-06-11,28.8,>=12,2013-11-03,2013-11-17,2014-05-18,12,2014-05-18,COMPLETED,Completed,14
CDISCPILOT02,02-710-1078,1078,710,710,Placebo,Placebo,0,Placebo,0,2013-09-17,2014-03-23,188,0,0,81,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,18,<25,152.4,41.7,12,2011-08-25,24.4,>=12,2013-09-06,2013-09-17,2014-03-23,12,2014-03-23,COMPLETED,Completed,21
CDISCPILOT02,02-710-1083,1083,710,710,Placebo,Placebo,0,Placebo,0,2013-07-22,2013-08-01,11,0,0,89,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,,Y,19,<25,157.5,47.2,14,2011-07-19,23.7,>=12,2013-07-09,2013-07-22,2013-08-03,4,2013-08-03,DEATH,Death,14
CDISCPILOT02,02-710-1137,1137,710,710,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-10-11,2013-11-13,34,69.1,2349,79,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,Y,,24,<25,165.1,65.3,16,2009-10-12,47.7,>=12,2013-10-03,2013-10-11,2013-11-13,7,2013-11-13,ADVERSE EVENT,Adverse Event,18
CDISCPILOT02,02-710-1142,1142,710,710,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-10-02,2012-10-20,19,59.7,1134,76,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,24.8,<25,152.4,57.6,12,2010-09-26,23.6,>=12,2012-09-12,2012-10-02,2012-10-23,5,2012-10-23,ADVERSE EVENT,Adverse Event,23
CDISCPILOT02,02-710-1183,1183,710,710,Placebo,Placebo,0,Placebo,0,2013-11-16,2014-05-17,183,0,0,80,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,21.2,<25,149.9,47.6,8,2012-10-25,12,>=12,2013-10-24,2013-11-16,2014-05-17,12,2014-05-17,COMPLETED,Completed,16
CDISCPILOT02,02-710-1187,1187,710,710,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-11-10,2013-05-12,184,76.7,14121,78,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,20.8,<25,154.9,49.9,8,2010-10-22,24.2,>=12,2012-10-26,2012-11-10,2013-05-12,12,2013-05-12,COMPLETED,Completed,11
CDISCPILOT02,02-710-1249,1249,710,710,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-12-28,2014-06-28,183,76.7,14040,79,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,25.4,25-<30,177.8,80.3,12,2008-12-27,59.8,>=12,2013-12-19,2013-12-28,2014-06-28,12,2014-06-28,COMPLETED,Completed,20
CDISCPILOT02,02-710-1264,1264,710,710,Placebo,Placebo,0,Placebo,0,2013-06-13,2013-10-11,121,0,0,78,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,Y,,29.1,25-<30,167.6,81.7,12,2010-06-06,35.9,>=12,2013-06-02,2013-06-13,2013-10-12,11,2013-10-12,ADVERSE EVENT,Adverse Event,14
CDISCPILOT02,02-710-1271,1271,710,710,Placebo,Placebo,0,Placebo,0,2012-09-27,2012-11-21,56,0,0,86,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,N,Y,N,N,Y,Y,,21.2,<25,149.9,47.6,16,2011-09-05,12,>=12,2012-09-04,2012-09-27,2012-12-02,8,2012-12-02,ADVERSE EVENT,Adverse Event,18
CDISCPILOT02,02-710-1278,1278,710,710,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-12-24,2013-02-26,65,74.8,4860,81,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,22.7,<25,177.8,71.7,20,2011-12-08,12.2,>=12,2012-12-13,2012-12-24,2013-03-03,9,2013-03-03,ADVERSE EVENT,Adverse Event,14
CDISCPILOT02,02-710-1314,1314,710,710,Placebo,Placebo,0,Placebo,0,2013-04-24,2013-05-23,30,0,0,78,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,N,N,N,N,Y,,,22.6,<25,137.2,42.6,12,2011-04-14,24.3,>=12,2013-04-21,2013-04-24,2013-05-25,6,2013-05-25,WITHDRAWAL BY SUBJECT,Withdrew Consent,12
CDISCPILOT02,02-710-1315,1315,710,710,Placebo,Placebo,0,Placebo,0,2013-02-27,2013-07-06,130,0,0,83,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,Y,,24.2,<25,152.4,56.3,12,2011-08-20,17.8,>=12,2013-02-12,2013-02-27,2013-07-16,11,2013-07-16,ADVERSE EVENT,Adverse Event,12
CDISCPILOT02,02-710-1354,1354,710,710,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-11-11,2013-05-01,172,77.1,13257,73,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,26.7,25-<30,182.9,89.4,16,2011-11-06,11.8,<12,2012-10-29,2012-11-11,2013-05-01,12,2013-05-01,COMPLETED,Completed,23
CDISCPILOT02,02-710-1368,1368,710,710,Placebo,Placebo,0,Placebo,0,2013-10-23,2014-04-24,184,0,0,88,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,15.7,<25,147.3,34,12,2011-10-12,24.3,>=12,2013-10-21,2013-10-23,2014-04-24,12,2014-04-24,COMPLETED,Completed,13
CDISCPILOT02,02-710-1408,1408,710,710,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-01-05,2013-07-12,189,76.1,14391,80,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,34.2,>=30,177.8,108,12,2007-12-14,60.5,>=12,2012-12-26,2013-01-05,2013-07-12,12,2013-07-12,COMPLETED,Completed,23
CDISCPILOT02,02-714-1035,1035,714,900,Placebo,Placebo,0,Placebo,0,2014-04-17,2014-10-16,183,0,0,88,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.6,<25,148.6,54.4,12,2011-04-02,36.1,>=12,2014-04-03,2014-04-17,2014-10-16,12,2014-10-16,COMPLETED,Completed,17
CDISCPILOT02,02-714-1288,1288,714,900,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-12-04,2014-06-17,196,76.2,14931,77,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,18.7,<25,162.6,49.4,6,2009-11-11,48.5,>=12,2013-11-24,2013-12-04,2014-06-17,12,2014-06-17,COMPLETED,Completed,19
CDISCPILOT02,02-714-1375,1375,714,900,Placebo,Placebo,0,Placebo,0,2013-02-26,2013-09-07,194,0,0,78,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,25.6,25-<30,149.9,57.6,10,2008-02-10,60.5,>=12,2013-02-23,2013-02-26,2013-09-07,12,2013-09-07,COMPLETED,Completed,17
CDISCPILOT02,02-714-1425,1425,714,900,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-08-15,2013-08-19,5,54,270,81,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,,,29,25-<30,177.8,91.6,16,2010-07-30,36.4,>=12,2013-08-11,2013-08-15,2013-08-22,4,2013-08-22,STUDY TERMINATED BY SPONSOR,Sponsor Decision,22
CDISCPILOT02,02-716-1024,1024,716,716,Placebo,Placebo,0,Placebo,0,2012-07-09,2013-01-20,196,0,0,87,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,22.7,<25,154.9,54.4,12,2011-12-01,7.2,<12,2012-07-06,2012-07-09,2013-01-20,12,2013-01-20,COMPLETED,Completed,22
CDISCPILOT02,02-716-1026,1026,716,716,Placebo,Placebo,0,Placebo,0,2014-04-02,2014-10-16,198,0,0,73,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,33.3,>=30,154.9,79.8,12,2010-09-02,42.7,>=12,2014-03-23,2014-04-02,2014-10-16,12,2014-10-16,COMPLETED,Completed,11
CDISCPILOT02,02-716-1030,1030,716,716,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-12-28,2014-01-02,6,54,324,83,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,,,33.2,>=30,150.6,75.3,12,2011-09-06,27.7,>=12,2013-12-25,2013-12-28,2014-01-10,4,2014-01-10,WITHDRAWAL BY SUBJECT,Withdrew Consent,16
CDISCPILOT02,02-716-1044,1044,716,716,Placebo,Placebo,0,Placebo,0,2013-04-27,2013-11-03,191,0,0,74,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,28.9,25-<30,172.7,86.2,12,2011-03-21,25,>=12,2013-04-20,2013-04-27,2013-11-03,12,2013-11-03,COMPLETED,Completed,14
CDISCPILOT02,02-716-1071,1071,716,716,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-06-08,2013-08-01,55,73.6,4050,78,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,32,>=30,154.9,76.7,12,2010-12-01,30.1,>=12,2013-06-03,2013-06-08,2013-08-01,8,2013-08-01,ADVERSE EVENT,Adverse Event,20
CDISCPILOT02,02-716-1108,1108,716,716,Placebo,Placebo,0,Placebo,0,2013-02-12,2013-08-10,180,0,0,86,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,26,25-<30,142.2,52.6,12,2012-02-14,11.7,<12,2013-02-04,2013-02-12,2013-08-10,12,2013-08-10,COMPLETED,Completed,21
CDISCPILOT02,02-716-1160,1160,716,716,Placebo,Placebo,0,Placebo,0,2013-04-05,2013-10-11,190,0,0,83,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.1,<25,157.5,59.9,12,2011-06-04,21.7,>=12,2013-03-23,2013-04-05,2013-10-11,12,2013-10-11,COMPLETED,Completed,23
CDISCPILOT02,02-716-1177,1177,716,716,Placebo,Placebo,0,Placebo,0,2014-09-02,2015-03-05,185,0,0,72,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,27.3,25-<30,177.8,86.2,12,2013-04-08,16.7,>=12,2014-08-29,2014-09-02,2015-03-05,12,2015-03-05,COMPLETED,Completed,21
CDISCPILOT02,02-716-1189,1189,716,716,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-10-09,2013-02-27,142,78,11070,81,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,N,Y,Y,,27.4,25-<30,163.8,73.5,9,2008-08-19,49.6,>=12,2012-10-07,2012-10-09,2013-03-03,11,2013-03-03,ADVERSE EVENT,Adverse Event,21
CDISCPILOT02,02-716-1229,1229,716,716,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-02-20,2013-03-31,40,70.9,2835,73,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,Y,,24.6,<25,161.3,64,16,2011-08-09,18.3,>=12,2013-02-14,2013-02-20,2013-04-02,7,2013-04-02,ADVERSE EVENT,Adverse Event,22
CDISCPILOT02,02-716-1308,1308,716,716,Placebo,Placebo,0,Placebo,0,2013-08-28,2013-10-07,41,0,0,76,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,N,N,N,Y,,,23.6,<25,157.5,58.5,13,2009-11-17,45.2,>=12,2013-08-23,2013-08-28,2013-10-07,7,2013-10-07,WITHDRAWAL BY SUBJECT,Withdrew Consent,13
CDISCPILOT02,02-716-1364,1364,716,716,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-07-04,2014-01-09,190,76.6,14553,84,>80,3,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,20.4,<25,162.6,54,12,2010-08-10,34.6,>=12,2013-06-27,2013-07-04,2014-01-09,12,2014-01-09,COMPLETED,Completed,17
CDISCPILOT02,02-716-1373,1373,716,716,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-12-14,2013-02-27,76,75,5697,74,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,32,>=30,147.3,69.4,16,2009-05-21,42.2,>=12,2012-11-24,2012-12-14,2013-02-28,9,2013-02-28,ADVERSE EVENT,Adverse Event,23
CDISCPILOT02,02-716-1418,1418,716,716,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-05-05,2013-11-20,200,77.1,15417,80,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,25.3,25-<30,165.1,69,8,2010-05-02,35.9,>=12,2013-04-27,2013-05-05,2013-11-20,12,2013-11-20,COMPLETED,Completed,20
CDISCPILOT02,02-716-1441,1441,716,716,Placebo,Placebo,0,Placebo,0,2014-01-22,2014-07-22,182,0,0,85,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,27.5,25-<30,144.8,57.6,10,2010-05-25,43.7,>=12,2014-01-13,2014-01-22,2014-07-22,12,2014-07-22,COMPLETED,Completed,22
CDISCPILOT02,02-716-1447,1447,716,716,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-12-16,2014-06-17,184,77.2,14202,72,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,24.2,<25,149.9,54.4,14,2010-05-15,42.9,>=12,2013-12-10,2013-12-16,2014-06-17,12,2014-06-17,COMPLETED,Completed,22
CDISCPILOT02,02-718-1101,1101,718,718,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-02-17,2013-07-31,165,78.5,12960,82,>80,3,YEARS,BLACK OR AFRICAN AMERICAN,2,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,Y,,,23.2,<25,186.2,80.3,12,2008-04-14,57.7,>=12,2013-02-01,2013-02-17,2013-08-02,12,2013-08-02,STUDY TERMINATED BY SPONSOR,Sponsor Decision,13
CDISCPILOT02,02-718-1139,1139,718,718,Placebo,Placebo,0,Placebo,0,2013-05-19,2013-11-17,183,0,0,77,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,22.4,<25,171.5,65.8,14,2008-03-29,61.2,>=12,2013-05-03,2013-05-19,2013-11-17,12,2013-11-17,COMPLETED,Completed,16
CDISCPILOT02,02-718-1150,1150,718,718,Placebo,Placebo,0,Placebo,0,2013-01-19,2013-07-29,192,0,0,73,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,22.5,<25,156.2,54.9,16,2012-03-11,10.1,<12,2013-01-12,2013-01-19,2013-07-31,12,2013-07-31,COMPLETED,Completed,22
CDISCPILOT02,02-718-1172,1172,718,718,Placebo,Placebo,0,Placebo,0,2013-09-21,2013-11-29,70,0,0,74,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,,,21.9,<25,174,66.2,21,2011-10-01,23.5,>=12,2013-09-15,2013-09-21,2013-11-29,9,2013-11-29,WITHDRAWAL BY SUBJECT,Withdrew Consent,10
CDISCPILOT02,02-718-1328,1328,718,718,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-02-01,2013-04-18,77,76.1,5859,86,>80,3,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,,,21.9,<25,170.2,63.5,12,2010-01-11,36.6,>=12,2013-01-28,2013-02-01,2013-05-01,9,2013-05-01,WITHDRAWAL BY SUBJECT,Withdrew Consent,13
CDISCPILOT02,02-718-1355,1355,718,718,Placebo,Placebo,0,Placebo,0,2013-02-28,2013-08-29,183,0,0,79,65-80,2,YEARS,WHITE,1,M,NOT HISPANIC OR LATINO,Y,Y,Y,Y,Y,Y,,,,20.8,<25,167.6,58.5,15,2008-12-05,50.3,>=12,2013-02-12,2013-02-28,2013-08-29,12,2013-08-29,COMPLETED,Completed,16
CDISCPILOT02,02-718-1371,1371,718,718,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2013-04-26,2013-08-01,98,77.4,7587,69,65-80,2,YEARS,WHITE,1,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,Y,,27.8,25-<30,154.9,66.7,10,2013-02-04,2.2,<12,2013-04-11,2013-04-26,2013-08-08,9,2013-08-08,ADVERSE EVENT,Adverse Event,16
CDISCPILOT02,02-718-1427,1427,718,718,Xanomeline High Dose,Xanomeline High Dose,81,Xanomeline High Dose,81,2012-12-17,2013-02-11,57,73.9,4212,74,65-80,2,YEARS,BLACK OR AFRICAN AMERICAN,2,F,NOT HISPANIC OR LATINO,Y,Y,Y,Y,N,N,Y,,,20.5,<25,158.8,51.7,16,2010-05-03,31.4,>=12,2012-12-13,2012-12-17,2013-02-18,8,2013-02-18,LACK OF EFFICACY,Lack of Efficacy,19
